73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Consumer health: Reducing your risk of lung cancer

Consumer health: Reducing your risk of lung cancer

by Laurel Kelly, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., accounting for about 1 in 5 of all cancer deaths, according to

Consumer health: Reducing your risk of lung cancer

by Laurel Kelly, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., accounting for about 1 in 5 of all cancer deaths, according to
AI assistance may improve accuracy of breast cancer screening

AI assistance may improve accuracy of breast cancer screening

A decision-referral approach could leverage the strengths of both the radiologist and artificial intelligence to improve the diagnostic capability for breast cancer screening, according to a study pub

AI assistance may improve accuracy of breast cancer screening

A decision-referral approach could leverage the strengths of both the radiologist and artificial intelligence to improve the diagnostic capability for breast cancer screening, according to a study pub
Key insights from statistical modeling of cancer patient life expectancy

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t
New device can detect cancer cells without invasive and expensive surgery

New device can detect cancer cells without invasive and expensive surgery

byUniversity of Technology, SydneyThe Static Droplet Microfluidic device. Credit: Dr. Majid WarkianiResearchers from the University of Technology Sydney have developed a new device that can dete

New device can detect cancer cells without invasive and expensive surgery

byUniversity of Technology, SydneyThe Static Droplet Microfluidic device. Credit: Dr. Majid WarkianiResearchers from the University of Technology Sydney have developed a new device that can dete
Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical
Discovery boosts the potential of new cancer-fighting drugs

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class
Targeted therapy extends survival in cancers of unknown primary

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814
To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu
Novel mechanism supports antitumor response and T-cell survival

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe
Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo
Study suggests a single dose of HPV vaccine provides years of protection from cancer

Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h

Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h